SCHEMBL6204091

SCHEMBL6204091

COc1cc([N+](=O)[O-])ccc1OCCN1CCCCC1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ MAPT P10636 4/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ HPGD P15428 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ LMNA P02545 4/20 0.43
▸ MCHR1 Q99705 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ ADRA1A P35348 2/20 0.40
▸ ADRA1B P35368 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KCNA3 P22001 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5388625 0.88 HRH3 (0.52) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL5381743 0.85 HRH3 (0.56) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL3860546 0.82 MCHR1 (0.51) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL3860554 0.82 MCHR1 (0.51) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL264564 0.82 LTA4H (0.57) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL5255573 0.81 MCHR1 (0.50) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL5381777 0.79 LTA4H (0.54) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL1928086 0.78 HRH3 (0.56) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL3863267 0.78 KDM4E (0.53) ALDH1A1MAPTSMN1; SMN2HPGDNPC1
SCHEMBL5389879 0.78 SMN1; SMN2 (0.47) ALDH1A1MAPTSMN1; SMN2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497265-A1 COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY GLAXO GROUP LIMITED (GB) 2005-01-19 — — EP disclosed
WO-2003089409-A1 COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY GLAXO GROUP LIMITED (GB) 2003-10-30 — — WO disclosed
Send feedback